Overview

Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to compare the rate and extent of absorption of Ranbaxy amlodipine 10 mg tablet to that of NorvascĀ® 10 mg tablet after a single, one tablet dose in fed state subjects.
Phase:
N/A
Details
Lead Sponsor:
Ranbaxy Laboratories Limited
Treatments:
Amlodipine